As shown during baseline characterisation of the in vitro model, we confirmed that Krox20 gene expression is significantly downregulated following WD (****P < 0.0001), whereas protein levels are increased at D3 (Figures 5A,E). The gene discussed is EGR2; the disease is Wilson disease.